Phase III study of atezolizumab (atezo) vs chemotherapy (chemo) in patients (pts) with treatment-naive advanced, recurrent or metastatic NSCLC unsuitable for platinum (plat)-based chemo

Lee, S. M. and Schulz, C. and Cardona, A. and Bartakova, P. and Peters, S. (2017) Phase III study of atezolizumab (atezo) vs chemotherapy (chemo) in patients (pts) with treatment-naive advanced, recurrent or metastatic NSCLC unsuitable for platinum (plat)-based chemo. ANNALS OF ONCOLOGY, 28 (Suppl5): 1376TIP. ISSN 0923-7534, 1569-8041

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Petra Gürster
Date Deposited: 14 Dec 2018 13:15
Last Modified: 17 Sep 2020 07:42
URI: https://pred.uni-regensburg.de/id/eprint/1207

Actions (login required)

View Item View Item